Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release titled "SPARC to provide update on R&D; Pipeline" which is being released by the Company, which is self-explanatory. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release titled "SPARC to provide update on R&D; Pipeline" which is being released by the Company, which is self-explanatory. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Update On Taclantis(r)
Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we inform you that it has come to our knowledge that a complaint has been filed by Abraxis Biosciences LLC in the U.S. District Court for the District of New Jersey, which alleges that SPARC's filing of New Drug Application (NDA) for Taclantis(r) injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the Orange Book listed patents for Abraxane(r). SPARC believes that this lawsuit is without merit and will vigorously defend against these allegations. Sun Pharma Advanced Research Company Ltd - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that the share certificate(s) as per attached details, issued by the Company, have been reported by the registered shareholder(s)/ bona fide purchasers to have been lost/ misplaced/stolen. Sun Pharma Advanced Research Company Ltd - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir/Madam, Pursuant to regulation 39(3) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that the share certificate(s) as per attached details, issued by the Company, have been reported by the registered shareholder(s)/ bona fide purchasers to have been lost/ misplaced/stolen. Sun Pharma Advanced Research Company Ltd - 532872 - Speech Delivered By Mr. Dilip Shanghvi, Chairman And Managing Director Of The Company At The 14Th Annual General Meeting Of The Company Held On 29Th July, 2019
Please find enclosed, copy of the Speech delivered by Mr. Dilip Shanghvi, Chairman and Managing Director of the Company at the 14th Annual General Meeting of the Company held on 29th July, 2019. Sun Pharma Advanced Research Company Ltd - 532872 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sun Pharma Advanced Research Company Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit herewith the details of the result of remote e-voting as well as e-Poll conducted at the Fourteenth Annual General Meeting (AGM) of Sun Pharma Advanced Research Company Limited held on 29th July, 2019 from 09:45 a.m. to 11:10 a.m. at Vasvik Auditorium, Trivia Complex, Race Course Road, Gautam Nagar, Vadiwadi, Vadodara - 390007, Gujarat, India in respect of all the resolutions as set out in the Notice dated 7th May, 2019 for your information and noting. Sun Pharma Advanced Research Company Ltd - 532872 - Proceedings Of 14Th Annual General Meeting
The 14th Annual General Meeting (AGM) of Sun Pharma Advanced Research Company Ltd. was held on Monday, 29th July, 2019 from 09:45 am to 11:10 am at Vasvik Auditorium, Trivia Complex, Race Course Road, Gautam Nagar, Vadiwadi, Vadodara - 390007, Gujarat, India. Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 the proceedings of the 14th Annual General Meeting is enclosed herewith for your record & dissemination. We request you to kindly take a note of the same. Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of Board Meeting - Results For The Quarter Ended June 2019
The Board of Directors of the Company at their meeting held from 12:45 pm to 04:00 pm today, inter alia, took on record and duly approved the Un-audited financial results of the Company for the quarter ended 30th June 2019 which is enclosed herewith along with the Limited Review Report of the Auditors thereon as Annexure I.